Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women

Climacteric

Volumn 9, Issue 6, 2006, Pages 464-472

  Osmanagaoglu M A ^a   Atasaral, T ^a   Baltaci, D ^a   Bozkaya, H ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Hormone therapy; Postmenopausal women; Sexual dysfunction

Indexed keywords

DIENOGEST; DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL; TIBOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEMALE SEXUAL FUNCTION INDEX; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SATISFACTION; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SINGLE BLIND PROCEDURE; VAGINAL DRYNESS;

AROUSAL; COITUS; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HORMONE ANTAGONISTS; HUMANS; LIBIDO; MIDDLE AGED; NANDROLONE; NORPREGNENES; PATIENT SATISFACTION; POSTMENOPAUSE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 33750614313     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600997775     Document Type: Article

References (20)

1. Walton B, Thorton T. Female sexual dysfunction. Curr Womens Health Rep 2003;3:319-26
2. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998;43:847-56
3. Oettel M, Carol W, Graser T, et al. Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations. Zentralbl Gynakol 1997;119:597-606
4. Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas 1998;30:295-305
5. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208
6. Murray W. Decreased libido in postmenopausal women. Nurse Pract Forum 2000;11:219-24
7. Phillips NA. Female sexual dysfunction: evaluation and treatment. Am Fam Physician 2000;62:127-36, 141-2
8. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004;11:120-30
9. Murray W. Decreased libido in postmenopausal women. Nurse Pract Forum 2000;11:219-24
10. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy - effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993;14:283-93
11. Dennerstein L, Burrows GD, Wood C, Hyman G. Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol 1980;56:316-22
12. Nathorst-Boos J, Wiklund I, Mattsson LA, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993;72:656-60
13. Teichmann A. Pharmacology of estradiol valerate/dienogest. Climacteric 2003;6(Suppl 2):17-23
14. Schneider HP. Androgens and antiandrogens. Ann N Y Acad Sci 2003;997:292-306
15. Rymer J, Chapman MG, Fogelman I, Wilson PO. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 1994;18:127-33
16. Palacios S, Menendez C, Jurado AR, Castano R, Vargas JC. Changes in sex behaviour after menopause: effects of tibolone. Maturitas 1995;22:155-61
17. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41
18. Egarter C, Topcuoglu A, Vogl S, Sator M. Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women. Acta Obstet Gynecol Scand 2002;81:649-53
19. Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76:231-8
20. Doren M, Rubig A, Coelingh Bennink HJ, Holzgreve W. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001;75:554-9